These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 17986257

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mechanism of multidrug resistance in relation to passive membrane permeation.
    Eytan GD.
    Biomed Pharmacother; 2005 Apr; 59(3):90-7. PubMed ID: 15795101
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport.
    Eckford PD, Sharom FJ.
    Biochemistry; 2008 Dec 23; 47(51):13686-98. PubMed ID: 19049391
    [Abstract] [Full Text] [Related]

  • 5. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
    Sachs-Barrable K, Thamboo A, Lee SD, Wasan KM.
    J Pharm Pharm Sci; 2007 Dec 23; 10(3):319-31. PubMed ID: 17727795
    [Abstract] [Full Text] [Related]

  • 6. The role of passive transbilayer drug movement in multidrug resistance and its modulation.
    Eytan GD, Regev R, Oren G, Assaraf YG.
    J Biol Chem; 1996 May 31; 271(22):12897-902. PubMed ID: 8662680
    [Abstract] [Full Text] [Related]

  • 7. Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells.
    Mankhetkorn S, Dubru F, Hesschenbrouck J, Fiallo M, Garnier-Suillerot A.
    Mol Pharmacol; 1996 Mar 31; 49(3):532-9. PubMed ID: 8643093
    [Abstract] [Full Text] [Related]

  • 8. Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells.
    Regev R, Assaraf YG, Eytan GD.
    Eur J Biochem; 1999 Jan 31; 259(1-2):18-24. PubMed ID: 9914470
    [Abstract] [Full Text] [Related]

  • 9. P-glycoprotein does not reduce substrate concentration from the extracellular leaflet of the plasma membrane in living cells.
    Chen Y, Pant AC, Simon SM.
    Cancer Res; 2001 Nov 01; 61(21):7763-9. PubMed ID: 11691790
    [Abstract] [Full Text] [Related]

  • 10. Chalcogenopyrylium dyes as inhibitors/modulators of P-glycoprotein in multidrug-resistant cells.
    Sawada GA, Raub TJ, William Higgins J, Brennan NK, Moore TM, Tombline G, Detty MR.
    Bioorg Med Chem; 2008 Nov 15; 16(22):9745-56. PubMed ID: 18849167
    [Abstract] [Full Text] [Related]

  • 11. Iodination increases the activity of verapamil derivatives in reversing PGP multidrug resistance.
    Barattin R, Gerby B, Bourges K, Hardy G, Olivares J, Boutonnat J, Arnoult C, D'Hardemare AD, Ronot X.
    Anticancer Res; 2010 Jul 15; 30(7):2553-9. PubMed ID: 20682982
    [Abstract] [Full Text] [Related]

  • 12. Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng.
    Choi CH, Kang G, Min YD.
    Planta Med; 2003 Mar 15; 69(3):235-40. PubMed ID: 12677527
    [Abstract] [Full Text] [Related]

  • 13. Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp.
    Molnár J, Kars MD, Gündüz U, Engi H, Schumacher U, Van Damme EJ, Peumans WJ, Makovitzky J, Gyémánt N, Molnár P.
    Acta Histochem; 2009 Mar 15; 111(4):329-33. PubMed ID: 19124148
    [Abstract] [Full Text] [Related]

  • 14. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.
    Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169
    [Abstract] [Full Text] [Related]

  • 15. Optimizing chemotherapy by measuring reversal of P-glycoprotein activity in plasma membrane vesicles.
    Köhler S, Stein WD.
    Biotechnol Bioeng; 2003 Mar 05; 81(5):507-17. PubMed ID: 12514799
    [Abstract] [Full Text] [Related]

  • 16. Characterization of binding properties to human P-glycoprotein: development of a [3H]verapamil radioligand-binding assay.
    Döppenschmitt S, Langguth P, Regårdh CG, Andersson TB, Hilgendorf C, Spahn-Langguth H.
    J Pharmacol Exp Ther; 1999 Jan 05; 288(1):348-57. PubMed ID: 9862789
    [Abstract] [Full Text] [Related]

  • 17. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X, Sun B, Zhu CJ, Yuan HQ, Shi YQ, Gao J, Li SJ, Lou HX.
    Toxicol In Vitro; 2009 Feb 05; 23(1):29-36. PubMed ID: 18938236
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Selective modulation of P-glycoprotein-mediated drug resistance.
    Bebawy M, Morris MB, Roufogalis BD.
    Br J Cancer; 2001 Dec 14; 85(12):1998-2003. PubMed ID: 11747345
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.